Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin.
Min Su YouJi-Kon RyuYoung Hoon ChoiJin Ho ChoiGunn HuhWoo Hyun PaikSang Hyub LeeYong-Tae KimPublished in: BMC cancer (2019)
GEMCIS demonstrated a high disease control rate in patients with unresectable GBC. Factors independently related to OS were metastasis to liver, NLR ≥ 3, CEA ≥ 5 ng/mL and CA19-9 ≥ 500 U/mL.